Delisting riskPopularity #4,127
Lexaria Bioscience (LEXX)
Developer and licensor of DehydraTECH oral drug-delivery technology.
$3.36
After hours+0.17 (+5.33%)
At close$3.19(−6.86%)
Something off on this page? Send us feedback.
Next report
Oct 28, 26
estimated · in 36 days
EPS estimate
−$0.90
Revenue estimate
$50.0K
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Jan '25Apr '25Jul '25Nov '25Jan '26Apr '26Jul '26Oct '26
Reported−$2.40−$2.25−$3.15−$2.10−$1.05−$0.90−$1.20Pending
Estimate−$1.80−$2.40−$2.25−$2.40−$1.95−$1.05−$0.90−$0.90
Surprise−33.3%+6.2%−40.0%+12.5%+46.2%+14.3%−33.3%—
RevenueReportedEstimate
Jan '25Apr '25Jul '25Nov '25Jan '26Apr '26Jul '26Oct '26
Reported$184.0K$174.0K$174.0K$200.0K—$20.0K—Pending
Estimate$100.0K$150.0K$137.0K$137.0K$100.0K$50.0K$50.0K$50.0K
Surprise+84.0%+16.0%+27.0%+46.0%—−60.0%——
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2027 | −$0.31 | — | — |
| May 2027 | −$0.30 | — | — |
| Feb 2027 | −$4.20 | — | — |
| Nov 2026 | −$0.29 | — | — |
| Oct 2026 | −$0.90 | — | — |
| Jul 2026 | −$0.90 | −$1.20 | −33.3% |
| Apr 2026 | −$1.05 | −$0.90 | +14.3% |
| Jan 2026 | −$1.95 | −$1.05 | +46.2% |
| Nov 2025 | −$2.40 | −$2.10 | +12.5% |
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Jan 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Jan 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Jan 2021 | |||
| Oct 2020 | |||
| Jun 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Nov 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 2027 | −$0.31 | — | — | $26.0K | — | — | — |
| May 2027 | −$0.30 | — | — | $24.9K | — | — | — |
| Feb 2027 | −$4.20 | — | — | $0 | — | — | — |
| Nov 2026 | −$0.29 | — | — | $22.8K | — | — | — |
| Oct 28, 2026 | −$0.90 | — | — | $50.0K | — | — | — |
| Jul 13, 2026 | −$0.90 | −$1.20 | −33.3% | $50.0K | — | — | −8.0% |
| Apr 13, 2026 | −$1.05 | −$0.90 | +14.3% | $50.0K | $20.0K | −60.0% | +7.7% |
| Jan 13, 2026 | −$1.95 | −$1.05 | +46.2% | $100.0K | — | — | +5.1% |
| Nov 26, 2025 | −$2.40 | −$2.10 | +12.5% | $137.0K | $200.0K | +46.0% | +3.7% |
| Jul 14, 2025 | |||||||
| Apr 14, 2025 | |||||||
| Jan 10, 2025 | |||||||
| Nov 26, 2024 | |||||||
| Jul 12, 2024 | |||||||
| Apr 12, 2024 | |||||||
| Jan 16, 2024 | |||||||
| Nov 21, 2023 | |||||||
| Jul 14, 2023 | |||||||
| Apr 14, 2023 | |||||||
| Jan 17, 2023 | |||||||
| Nov 25, 2022 | |||||||
| Jul 14, 2022 | |||||||
| Apr 11, 2022 | |||||||
| Jan 14, 2022 | |||||||
| Nov 29, 2021 | |||||||
| Jul 15, 2021 | |||||||
| Apr 14, 2021 | |||||||
| Jan 14, 2021 | |||||||
| Oct 14, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Apr 2, 2020 | |||||||
| Jan 8, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Jul 8, 2019 | |||||||
| Apr 12, 2019 | |||||||
| Jan 11, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Jul 13, 2018 | |||||||
| Apr 12, 2018 | |||||||
| Jan 12, 2018 | |||||||
| Nov 27, 2017 | |||||||
| Jul 13, 2017 | |||||||
| Apr 13, 2017 | |||||||
| Jan 13, 2017 | |||||||
| Nov 29, 2016 | |||||||
| Jul 13, 2016 | |||||||
| Apr 13, 2016 | |||||||
| Jan 8, 2016 | |||||||
| Nov 27, 2015 | |||||||
| Jul 13, 2015 |